
Number of publications published per year by Lleo, Ana. (Source : PubMed)

Distribution of publications types for Lleo, Ana. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
gamma-Secretase as a therapeutic target in Alzheimer's disease.
Curr Drug Targets
2010;11;4
Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C.
J. Hepatol.
2010

Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis.
Ann. N. Y. Acad. Sci.
2009;1173

Primary biliary cirrhosis is associated with altered hepatic microRNA expression.
J. Autoimmun.
2009;32;3-4

Apotopes and the biliary specificity of primary biliary cirrhosis.
Hepatology
2009;49;3

The consequences of apoptosis in autoimmunity.
J. Autoimmun.
2008;31;3

Etiopathogenesis of primary biliary cirrhosis.
World J. Gastroenterol.
2008;14;21
Current therapeutic options for Alzheimer's disease.
Curr. Genomics
2007;8;8

Autophagy: highlighting a novel player in the autoimmunity scenario.
J. Autoimmun.
2007;29;2-3

Interpreting serological tests in diagnosing autoimmune liver diseases.
Semin. Liver Dis.
2007;27;2
[ See timeline ] [ See all publications ]
means that Lleo, Ana has 8 papers cited a least 8 times - methodology
Division of Rheumatology, University of California at Davis, Davis, CA 95616, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.